Advertisement

Gastric Cancer

, Volume 21, Issue 5, pp 729–737 | Cite as

Family history of cancer in first-degree relatives and risk of gastric cancer and its precursors in a Western population

  • Minkyo Song
  • M. Constanza Camargo
  • Stephanie J. Weinstein
  • Ana F. Best
  • Satu Männistö
  • Demetrius Albanes
  • Charles S. Rabkin
Original Article
  • 158 Downloads

Abstract

Background

Family history may inform risks of gastric cancer and preneoplastic lesions.

Methods

We examined associations with history of cancer in first-degree relatives for 307 incident gastric cancer cases among 20,720 male smokers in a prospective study in Finland. Cox regression was used to calculate gastric cancer hazard ratios (HR) and 95% confidence intervals (95% CI). Logistic regression was used to estimate odds ratios (OR) and 95% CIs for low serum pepsinogen, a marker of gastric atrophy.

Results

Gastric cancer risk was associated with gastric cancer history in first-degree relatives overall (HR 1.56, 95% CI 1.15–2.12), in fathers (HR 1.67, 95% CI 1.09–2.55) and in siblings (HR 2.05, 95% CI 1.25–3.38). Associations were significant for noncardia (HR 1.83, 95% CI 1.30–2.57) but not cardia (HR 0.93, 95% CI 0.46–1.87) cancers, and marginal for both intestinal—(HR 1.53, 95% CI 0.92–2.55) and diffuse-type (HR 1.47, 95% CI 0.72–3.03) histologies. Family history of other cancer types was not associated with gastric cancer risk. Family history of gastric cancer was associated with low pepsinogen (OR 1.29, 95% CI 1.11–1.50).

Conclusions

Family history of gastric cancer is strongly associated with specific subtypes of gastric cancer as well as with gastric atrophy, a risk factor for developing this malignancy.

Keywords

Family history Gastric cancer Gastric atrophy Risk factors Caucasians 

Notes

Acknowledgements

This study was supported by the Intramural Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services. The ATBC Study was supported by funding provided by the Intramural Research Program of the National Cancer Institute and US Public Health Service contracts [HHSN261201500005C].

Compliance with ethical standards

Human rights statement and informed consent

All procedures were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1964 and later versions. The study was approved by the Institutional Review Boards of both the National Cancer Institute, Bethesda, Maryland, USA and the National Public Health Institute, Helsinki, Finland. All participants provided written informed consent.

Conflict of interest

The authors declare no conflict of interest.

Supplementary material

10120_2018_807_MOESM1_ESM.docx (2.4 mb)
Supplementary material 1 (DOCX 2443 kb) Forest plots for the association of family history of gastric cancer and gastric cancer risk. Abbreviation GC = gastric cancer; young GC; gastric cancers restricted to age 18–45. case%, control% indicate% of gastric cancer family history in cases and controls, respectively

References

  1. 1.
    Ferlay J, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.CrossRefPubMedGoogle Scholar
  2. 2.
    Inoue M, Tsugane S. Epidemiology of gastric cancer in Japan. Postgrad Med J. 2005;81(957):419–24.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Song M, Lee H, Kang D. Epidemiology and screening of gastric cancer in Korea. J Korean Med Assoc. 2015;58(3):183–90.CrossRefGoogle Scholar
  4. 4.
    Camargo MC, et al. Divergent trends for gastric cancer incidence by anatomical subsite in US adults. Gut. 2011;60(12):1644–9.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Botterweck AA, et al. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol. 2000;29(4):645–54.CrossRefPubMedGoogle Scholar
  6. 6.
    Song M, et al. Age and sex interactions in gastric cancer incidence and mortality trends in Korea. Gastric Cancer. 2015;18(3):580–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Shen L, et al. Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol. 2013;14(12):e535–47.CrossRefPubMedGoogle Scholar
  8. 8.
    Orditura M, et al. Treatment of gastric cancer. World J Gastroenterol. 2014;20(7):1635–49.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Rosati G, Ferrara D, Manzione L. New perspectives in the treatment of advanced or metastatic gastric cancer. World J Gastroenterol. 2009;15(22):2689–92.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Yoon PW, et al. Can family history be used as a tool for public health and preventive medicine? Genet Med. 2002;4(4):304–10.CrossRefPubMedGoogle Scholar
  11. 11.
    Guttmacher AE, Collins FS, Carmona RH. The family history-more important than ever. N Engl J Med. 2004;351(22):2333–6.CrossRefPubMedGoogle Scholar
  12. 12.
    Yaghoobi M, Bijarchi R, Narod SA. Family history and the risk of gastric cancer. Br J Cancer. 2010;102(2):237–42.CrossRefPubMedGoogle Scholar
  13. 13.
    The ATBC Cancer Prevention Study Group. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol. 1994;4(1):1–10.Google Scholar
  14. 14.
    Korhonen P, et al. The Finnish Cancer Registry as follow-up source of a large trial cohort–accuracy and delay. Acta Oncol. 2002;41(4):381–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.CrossRefPubMedGoogle Scholar
  16. 16.
    Varis K, et al. Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Helsinki Gastritis Study Group. Scand J Gastroenterol. 2000;35(9):950–6.CrossRefPubMedGoogle Scholar
  17. 17.
    Wang M, et al. Statistical methods for studying disease subtype heterogeneity. Stat Med. 2016;35(5):782–800.CrossRefPubMedGoogle Scholar
  18. 18.
    Higgins JP, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Eom BW, et al. Prediction model for gastric cancer incidence in Korean population. PLoS ONE. 2015;10(7):e0132613.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Charvat H, et al. Prediction of the 10-year probability of gastric cancer occurrence in the Japanese population: the JPHC study cohort II. Int J Cancer. 2016;138(2):320–31.CrossRefPubMedGoogle Scholar
  21. 21.
    Yatsuya H, et al. Individual and joint impact of family history and Helicobacter pylori infection on the risk of stomach cancer: a nested case–control study. Br J Cancer. 2004;91(5):929–34.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Vieira AR, et al. Foods and beverages and colorectal cancer risk: a systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR continuous update project. Ann Oncol. 2017;28(8):1788–802.CrossRefPubMedGoogle Scholar
  23. 23.
    Fitzgerald RC, et al. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet. 2010;47(7):436–44.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Pharoah PD, et al. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology. 2001;121(6):1348–53.CrossRefPubMedGoogle Scholar
  25. 25.
    Dhillon PK, et al. Family history of cancer and risk of esophageal and gastric cancers in the United States. Int J Cancer. 2001;93(1):148–52.CrossRefPubMedGoogle Scholar
  26. 26.
    Safaee A, et al. Family history of cancer and risk of gastric cancer in Iran. Asian Pac J Cancer Prev. 2011;12(11):3117–20.PubMedGoogle Scholar
  27. 27.
    Foschi R, et al. Family history of cancer and stomach cancer risk. Int J Cancer. 2008;123(6):1429–32.CrossRefPubMedGoogle Scholar
  28. 28.
    Eto K, et al. Familial clustering in subgroups of gastric cancer stratified by histology, age group and location. Eur J Surg Oncol. 2006;32(7):743–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Bakir T, et al. Gastric cancer and other organ cancer history in the parents of patients with gastric cancer. Eur J Cancer Prev. 2003;12(3):183–9.CrossRefPubMedGoogle Scholar
  30. 30.
    Minami Y, Tateno H. Associations between cigarette smoking and the risk of four leading cancers in Miyagi Prefecture, Japan: a multi-site case–control study. Cancer Sci. 2003;94(6):540–7.CrossRefPubMedGoogle Scholar
  31. 31.
    Lissowska J, et al. Family history and risk of stomach cancer in Warsaw, Poland. Eur J Cancer Prev. 1999;8(3):223–7.CrossRefPubMedGoogle Scholar
  32. 32.
    Inoue M, et al. Family history and subsite of gastric cancer: data from a case-referent study in Japan. Int J Cancer. 1998;76(6):801–5.CrossRefPubMedGoogle Scholar
  33. 33.
    Gajalakshmi CK, Shanta V. Lifestyle and risk of stomach cancer: a hospital-based case–control study. Int J Epidemiol. 1996;25(6):1146–53.CrossRefPubMedGoogle Scholar
  34. 34.
    La Vecchia C, et al. Family history and the risk of stomach and colorectal cancer. Cancer. 1992;70(1):50–5.CrossRefPubMedGoogle Scholar
  35. 35.
    Turati F, et al. Family history of cancer and the risk of cancer: a network of case–control studies. Ann Oncol. 2013;24(10):2651–6.CrossRefPubMedGoogle Scholar
  36. 36.
    Huang X, et al. Effect of life styles on the risk of subsite-specific gastric cancer in those with and without family history. J Epidemiol. 1999;9(1):40–5.CrossRefPubMedGoogle Scholar
  37. 37.
    Palli D, et al. Family history and risk of stomach cancer in Italy. Cancer Epidemiol Biomarkers Prev. 1994;3(1):15–8.PubMedGoogle Scholar
  38. 38.
    Weyermann M, Rothenbacher D, Brenner H. Acquisition of Helicobacter pylori infection in early childhood: independent contributions of infected mothers, fathers, and siblings. Am J Gastroenterol. 2009;104(1):182–9.CrossRefPubMedGoogle Scholar
  39. 39.
    Shin CM, et al. Stomach cancer risk in gastric cancer relatives: interaction between Helicobacter pylori infection and family history of gastric cancer for the risk of stomach cancer. J Clin Gastroenterol. 2010;44(2):e34–9.CrossRefPubMedGoogle Scholar
  40. 40.
    Garcia-Gonzalez MA, et al. Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: a nationwide multicenter study in Spain. Am J Gastroenterol. 2007;102(9):1878–92.CrossRefPubMedGoogle Scholar
  41. 41.
    Gao Y, et al. Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China. BMC Cancer. 2009;9:269.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Samloff IM. Immunologic studies of human group I pepsinogens. J Immunol. 1971;106(4):962–8.PubMedGoogle Scholar
  43. 43.
    Samloff IM, et al. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology. 1982;83(1 Pt 2):204–9.PubMedGoogle Scholar
  44. 44.
    Ren JS, et al. Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohort. Gut. 2009;58(5):636–42.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Di Mario F, et al. ‘Serological biopsy’ in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection. Scand J Gastroenterol. 2003;38(12):1223–7.CrossRefPubMedGoogle Scholar
  46. 46.
    Adamu MA, et al. Incidence and risk factors for the development of chronic atrophic gastritis: five year follow-up of a population-based cohort study. Int J Cancer. 2011;128(7):1652–8.CrossRefPubMedGoogle Scholar
  47. 47.
    Nishizawa T, et al. Family history is an independent risk factor for the progression of gastric atrophy among patients with Helicobacter pylori infection. United Eur Gastroenterol J. 2017;5(1):32–6.CrossRefGoogle Scholar
  48. 48.
    Wang JT, et al. Direct DNA amplification and restriction pattern analysis of Helicobacter pylori in patients with duodenal ulcer and their families. J Infect Dis. 1993;168(6):1544–8.CrossRefPubMedGoogle Scholar
  49. 49.
    Blecker U, et al. Evolution of Helicobacter pylori positivity in infants born from positive mothers. J Pediatr Gastroenterol Nutr. 1994;19(1):87–90.CrossRefPubMedGoogle Scholar
  50. 50.
    Ashorn M, et al. Seroepidemiological study of Helicobacter pylori infection in infancy. Arch Dis Child Fetal Neonatal Ed. 1996;74(2):F141–2.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Gold BD, et al. Helicobacter pylori acquisition in infancy after decline of maternal passive immunity. Pediatr Res. 1997;41(5):641–6.CrossRefPubMedGoogle Scholar
  52. 52.
    Murff HJ, Spigel DR, Syngal S. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA. 2004;292(12):1480–9.CrossRefPubMedGoogle Scholar
  53. 53.
    Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods, vol. xix. Belmont: Lifetime Learning Publications; 1982. p. 529.Google Scholar
  54. 54.
    Oliveira C, et al. Familial gastric cancer: genetic susceptibility, pathology, and implications for management. Lancet Oncol. 2015;16(2):e60–70.CrossRefPubMedGoogle Scholar
  55. 55.
    McLean MH, El-Omar EM. Genetics of gastric cancer. Nat Rev Gastroenterol Hepatol. 2014;11(11):664–74.CrossRefPubMedGoogle Scholar
  56. 56.
    Sereno M, et al. Gastric tumours in hereditary cancer syndromes: clinical features, molecular biology and strategies for prevention. Clin Transl Oncol. 2011;13(9):599–610.CrossRefPubMedGoogle Scholar

Copyright information

© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2018

Authors and Affiliations

  1. 1.Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, Department of Health and Human ServicesNational Cancer Institute, National Institutes of HealthBethesdaUSA
  2. 2.Department of Public Health SolutionsNational Institute for Health and WelfareHelsinkiFinland

Personalised recommendations